Sobreiro, M.d.F.M.; Silveira, P.S.P.; Cavenaghi, V.B.; da Costa, L.P.; de Souza, B.P.F.; Takahashi, R.E.S.; Starek, R.V.M.; Siqueira, J.O.; Fraguas, R.
Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals 2025, 18, 173.
https://doi.org/10.3390/ph18020173
AMA Style
Sobreiro MdFM, Silveira PSP, Cavenaghi VB, da Costa LP, de Souza BPF, Takahashi RES, Starek RVM, Siqueira JO, Fraguas R.
Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals. 2025; 18(2):173.
https://doi.org/10.3390/ph18020173
Chicago/Turabian Style
Sobreiro, Matildes de Freitas Menezes, Paulo Sergio Panse Silveira, Vitor Breseghello Cavenaghi, Leandro Paulino da Costa, Bruno Pinatti Ferreira de Souza, Rachel Emy Straus Takahashi, Renato Vianna Marotta Starek, José Oliveira Siqueira, and Renerio Fraguas.
2025. "Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report" Pharmaceuticals 18, no. 2: 173.
https://doi.org/10.3390/ph18020173
APA Style
Sobreiro, M. d. F. M., Silveira, P. S. P., Cavenaghi, V. B., da Costa, L. P., de Souza, B. P. F., Takahashi, R. E. S., Starek, R. V. M., Siqueira, J. O., & Fraguas, R.
(2025). Long-Term Cognitive Outcomes of Esketamine Nasal Spray in Treatment-Resistant Depression: A Preliminary Report. Pharmaceuticals, 18(2), 173.
https://doi.org/10.3390/ph18020173
